Madrigal Pharmaceuticals Analyst Ratings

BenzingaJan 10 23:57 · Ratings

Madrigal Pharmaceuticals' Rezdiffra Shows Strong Market Growth and Positive Outlook, Justifying Buy Rating

TipRanksJan 10 13:35 · Ratings

JMP Securities Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Raises Target Price to $427

Futu NewsJan 10 13:32 · Ratings

BofA Securities Maintains Madrigal Pharmaceuticals(MDGL.US) With Sell Rating, Announces Target Price $155

Futu NewsJan 6 19:31 · Ratings

SA Asks: Which Biotechs Are Most Likely to Be Acquired Near-term?

Seeking AlphaJan 6 06:32

Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Madrigal PharmaceuticalsJan 3 13:00